DE69005860D1 - Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln. - Google Patents

Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln.

Info

Publication number
DE69005860D1
DE69005860D1 DE90104640T DE69005860T DE69005860D1 DE 69005860 D1 DE69005860 D1 DE 69005860D1 DE 90104640 T DE90104640 T DE 90104640T DE 69005860 T DE69005860 T DE 69005860T DE 69005860 D1 DE69005860 D1 DE 69005860D1
Authority
DE
Germany
Prior art keywords
methylthioadenosine
deoxy
seborrhea
salts
adenosylmethionine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90104640T
Other languages
English (en)
Other versions
DE69005860T2 (de
Inventor
Moratti Emanuela Maggioni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KNOLL-RAVIZZA FARMACEUTICI S.P.A., CAMPOVERDE DI A
Original Assignee
Bioresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch SRL filed Critical Bioresearch SRL
Application granted granted Critical
Publication of DE69005860D1 publication Critical patent/DE69005860D1/de
Publication of DE69005860T2 publication Critical patent/DE69005860T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE90104640T 1989-03-13 1990-03-12 Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln. Expired - Lifetime DE69005860T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919737A IT1229477B (it) 1989-03-13 1989-03-13 Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
DE69005860D1 true DE69005860D1 (de) 1994-02-24
DE69005860T2 DE69005860T2 (de) 1994-04-28

Family

ID=11160803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90104640T Expired - Lifetime DE69005860T2 (de) 1989-03-13 1990-03-12 Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln.

Country Status (11)

Country Link
US (1) US5753213A (de)
EP (1) EP0387756B1 (de)
JP (1) JPH0778011B2 (de)
KR (1) KR900013969A (de)
AT (1) ATE99945T1 (de)
CA (1) CA2012046C (de)
DE (1) DE69005860T2 (de)
DK (1) DK0387756T3 (de)
ES (1) ES2062137T3 (de)
IT (1) IT1229477B (de)
ZA (1) ZA901929B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247903B (it) * 1991-02-25 1995-01-05 Bioresearch Spa Impiego della s-adenosil-l-metionina nel trattamento della colestasi intraepatica da nutrizione parenterale totale
KR100309141B1 (ko) * 1998-04-13 2001-12-28 조영동 5'-데옥시-5'-메틸티오아데노신을이용한면역분석방법
DE10132338A1 (de) * 2001-07-04 2003-01-16 Basf Ag Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
ITMI20012462A1 (it) 2001-11-22 2003-05-22 Gnosis Srl Processo per la preparazione di compresse comprendenti s-adenosilmetionina
ITMI20032393A1 (it) * 2003-12-05 2005-06-06 Applied Pharma Res Composizioni contenenti metilioadenosina-mta-e loro uso topico.
US7406746B2 (en) * 2004-08-31 2008-08-05 Bushey Richard D Slider for heavy loads
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
AU2006237346B2 (en) * 2005-04-20 2011-04-07 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression in plants
AU2008210327B2 (en) * 2007-01-31 2011-06-16 Methylation Sciences International Srl Extended release pharmaceutical formulations of S-adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20100062993A1 (en) * 2008-09-11 2010-03-11 Yochanan R. Bulka Adenosine Nucleotides as Dietary Supplements and as Agents in the Prevention of Cancer and the Metastasis Thereof
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
WO2014163152A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA7469B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferative skin diseases with-c-amp analogs
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4496588A (en) * 1977-07-11 1985-01-29 Merrell Toraude Et Compagnie Method of treating psoriasis
US4373097A (en) * 1981-04-27 1983-02-08 Bioresearch S.R.L. Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
FR2580478B1 (fr) * 1985-04-17 1989-05-12 Christian Chapoton Dispositif de traitement capillaire liberant une substance active et procede de fabrication
EP0216357A3 (de) * 1985-09-25 1988-08-31 Nippon Zeon Co., Ltd. Phosphoramidit-Verbindungen und Verfahren zu deren Herstellung
GB8607265D0 (en) * 1986-03-24 1986-04-30 London King S College Protecting groups of organic synthesis
JPH01502187A (ja) * 1986-12-02 1989-08-03 サントル・ナシオナル・ド・ラ・ルシェルシュ・シアンティフィック・（セ・エヌ・エール・エス） α―オリゴヌクレオチド
FR2623396B1 (fr) * 1987-11-25 1990-03-30 Sanofi Sa Utilisation de l'ademetionine contre le vieillissement de la peau

Also Published As

Publication number Publication date
IT1229477B (it) 1991-09-03
CA2012046C (en) 2001-02-13
KR900013969A (ko) 1990-10-22
CA2012046A1 (en) 1990-09-13
IT8919737A0 (it) 1989-03-13
ES2062137T3 (es) 1994-12-16
US5753213A (en) 1998-05-19
DK0387756T3 (da) 1994-03-07
ATE99945T1 (de) 1994-01-15
JPH0368520A (ja) 1991-03-25
DE69005860T2 (de) 1994-04-28
EP0387756A1 (de) 1990-09-19
ZA901929B (en) 1990-12-28
JPH0778011B2 (ja) 1995-08-23
EP0387756B1 (de) 1994-01-12

Similar Documents

Publication Publication Date Title
ATE108794T1 (de) Therapeutische nucleoside und deren herstellung.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DE3883035D1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
AU4732989A (en) Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines
DE69005860D1 (de) Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln.
AU637086B2 (en) Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
GR3007790T3 (de)
ATE231863T1 (de) 6-amino-purinderivate mit pde-iv inhibierender wirkung
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
DE68901216D1 (de) Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.
DE69005160D1 (de) Verwendung von 5'-Deoxy-5'-methylthioadenosin, s-Adenylmethionin und deren Salzen zur Herstellung pharmazeutischer Präparate zur Förderung des Haarwuchses bei Patienten mit Kahlköpfigkeit.
IT8920358A0 (it) Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
HUT71838A (en) Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
AU636876B2 (en) Use of 5'deoxy-5'methylthioadenosine, s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions, and the pharmaceutical compositions concerned
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ITMI910133A1 (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8620713A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per la loro prepazione e relative compisizioni farmaceutiche.
IT1262929B (it) Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KNOLL FARMACEUTICI S.P.A., MUGGIO, MAILAND/MILANO,

8327 Change in the person/name/address of the patent owner

Owner name: KNOLL-RAVIZZA FARMACEUTICI S.P.A., CAMPOVERDE DI A